Evidence map›Paper›PMID 39899785›Full record

ReviewNeurology2025

Statistical Practice of Ordinal Outcome Analysis in Neurologic Trials: A Literature Review.

Yongxi Long, Sophie C de Ruiter, Linda W G Luijten, Eveline J A Wiegers, Diederik W J Dippel, Pieter A Van Doorn, Bart C Jacobs, Ewout W Steyerberg

Erratum issuedAbstract readReview
In one paragraph

Review in Neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Yongxi LongBiomedical Data Sciences, Leiden University Medical Center, the Netherlands.ORCID 0009-0002-8871-152X
Sophie C de RuiterJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, the Netherlands.ORCID 0000-0002-1871-1033
Linda W G LuijtenDepartment of Neurology, Erasmus MC, Rotterdam, the Netherlands; and.
Eveline J A WiegersDepartment of Neurology, Erasmus MC, Rotterdam, the Netherlands; and.ORCID 0000-0003-3219-210X
Diederik W J DippelDepartment of Neurology, Erasmus MC, Rotterdam, the Netherlands; and.ORCID 0000-0002-9234-3515
Pieter A Van DoornDepartment of Neurology, Erasmus MC, Rotterdam, the Netherlands; and.ORCID 0000-0003-2584-3357
Bart C JacobsDepartment of Neurology, Erasmus MC, Rotterdam, the Netherlands; and.ORCID 0000-0002-8985-2458
Ewout W SteyerbergBiomedical Data Sciences, Leiden University Medical Center, the Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

objectivesOrdinal scales are widely adopted as outcome measures in neurologic randomized controlled trials (RCTs). We aimed to evaluate which statistical methods have been used to test and estimate treatment effects from ordinal outcomes in recent RCTs across a range of acute neurologic diseases.

methodsWe searched PubMed for RCTs in 5 acute monophasic neurologic diseases (stroke, traumatic brain injury [TBI], subarachnoid hemorrhage [SAH], meningitis, and Guillain-Barré syndrome [GBS]) published in high-impact journals between January 1, 2015, and November 1, 2023. Trials had to report on an ordinal scale as the primary or secondary efficacy outcome. Two independent reviewers performed study screening and data extraction. We evaluated the results to determine how investigators (1) addressed the ordinal nature of outcomes, (2) assessed and reported key assumptions, (3) used longitudinal measurements, and (4) adjusted for prognostic covariates.

resultsWe reviewed 70 RCTs for treatment evaluations in stroke (n = 36), TBI (n = 13), SAH (n = 10), meningitis (n = 7), and GBS (n = 4). In 46 of 70 trials (66%), investigators retained the full ordering information, commonly analyzed using a proportional odds model (33/46 trials, 72%). The proportional odds assumption was not addressed in 23 of 33 trials (62%). In 22 of 70 trials (31%), the ordinal outcome was dichotomized, with notable variation in the cut-point for each ordinal scale. In 41 of 70 trials (59%), the ordinal outcome was assessed at multiple time points while some form of longitudinal data analysis was performed in only 3 of these 41 studies (7%). The time point chosen for analysis varied within neurologic conditions. Covariate adjustment was reported in 48 of 70 studies (69%). DISCUSSION: There is a large variation in the current practice of analyzing ordinal outcomes in neurologic trials. Dichotomization and focus on a single time point are common; therefore, information contained in the rank ordering of the outcome and repeated measurements is not fully used. Further research needs to clarify the balance between maximizing the statistical power, making assumptions, and allowing for straightforward interpretations in approaches that make more effective use of the outcome data.

Indexed as

Nervous System DiseasesOutcome Assessment, Health CareRandomized Controlled Trials as TopicBrain Injuries, TraumaticHumansSubarachnoid Hemorrhage

Identifiers

PMID39899785
PMCPMC11793924

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.